期刊文献+

灯盏花素佐治AECOPD的临床效果观察 被引量:7

下载PDF
导出
摘要 目的观察灯盏花素佐治慢性阻塞性肺疾病急性加重期(AECOPD)的临床效果。方法将200例AECOPD患者随机分为观察组和对照组各100例。对照组给予常规治疗,观察组在对照组基础上加用灯盏花素治疗。均以14d为一疗程。对比2组咳嗽缓解时间、咯痰缓解时间、哮鸣音缓解时间和住院时间;对比2组治疗前后生活质量改善情况。结果观察组咳嗽缓解时间,咯痰缓解时间,哮鸣音缓解时间和住院时间均短于对照组(P<0.05)。对照组治疗后第1周生活质量评分虽低于治疗前,但差异无统计学意义(P>0.05),第2周生活质量评分低于治疗前(P<0.05)。观察组治疗后第1、2周生活质量评分均低于治疗前(P<0.05或P<0.01),且低于对照组(P<0.05)。结论灯盏花素佐治AECOPD,提高了患者的生活质量,且无明显不良反应,值得临床推广应用。
出处 《临床合理用药杂志》 2015年第28期35-36,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献3

二级参考文献18

  • 1Perera P N, Armstrong E P, Sherrill D L, et al. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality[J]. COPD,2012,9(2) :131 -41.
  • 2Rothberg M B, Pekow P S, Lahti M, et al. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease [J]. JAMA, 2010, 303 (20) :2035 -42.
  • 3Li S, Huang X, Chen Z, et al. Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis[J]. Int J Infect Dis, 2013,17(1) :e12 -23.
  • 4Hanania N A, Marciniuk D D. A unified front against COPD: clinical practice guidelines from the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society [J ] . Chest, 2011,140(3) :565 -6.
  • 5Garcia-Rio F, Miravitlles M, Soriano J B, et al. Systemic inflammation in chronic obstructive pulmonary disease: a populationbased study[J]. Respir Res, 2010,11(1) :63.
  • 6Agusti A, Edwards L D, Rennard S I, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype[J]. PLoS One, 2012,7(5) :e37483.
  • 7Yu Z, Liu J, Sun Q, et al. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis [J]. Scand J Infect Dis, 2010,42(10) :723 -33.
  • 8Danikas D D, Karakantza M, Theodorou G L, et al. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression [J]. Clin Exp Immunol, 2008,154 (1) :87 - 97.
  • 9Oppegaard 0, Skodvin B, Halse A K, et al. CD64 as a potential biomarker in septic arthritis[J]. BMC Infect Dis, 2013,13:278.
  • 10Streimish I, Bizzarro M, Northrup V, et al. Neutrophil CD64 with hematologic criteria for diagnosis of neonatal sepsis [J]. Am J Perinatol ,2014 ,31 (1) :21 - 30.

共引文献24

同被引文献64

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部